...
首页> 外文期刊>Panminerva medica >Treatment of heart failure and ascites with ultrafiltration in patients with intractable alcoholic cardiomyopathy.
【24h】

Treatment of heart failure and ascites with ultrafiltration in patients with intractable alcoholic cardiomyopathy.

机译:难治性酒精性心肌病患者的超滤治疗心力衰竭和腹水。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In Western countries the excess of alcohol intake causes, secondary, non ischaemic cardiomyopathy and cirrhosis. Frequently, therapy is not effective so ultrafiltration was tried on patients affected, with positive effects on life quality. We tried to verify utility and tolerance to peritoneal ultrafiltration in a group of subjects affected by heart failure secondary to alcoholic cardiomyopathy, refractory to conventional therapy. METHODS: Sixteen patients (14 males, 2 females) with heart failure and ascites affected by alcoholic cardiomyopathy were studied. All subjects were in IV class NYHA (New York Heart Association); ejection fraction (EF) was evaluated by echocardiogram and ascites by abdominal ultrasound. Patients were submitted to clinical exam, body weight, abdominal circumference, diuresis and routine biohumoral exams, electrocardiogram and chest X-ray. Subsequently they underwent intermittent nocturnal peritoneal dialysis with a changing cycle of 6-12 hours per session. After 5 days, subjects were checked through echocardiogram and abdominal ultrasound. RESULTS: The patients mean age was 56.7 +/- 3.2 years. After ultrafiltration, all subjects showed decreased body weight, abdominal circumference and urea; there was an increase of diuresis and Natriuria. Fifteen subjects entered III NYHA class without variation of EF; all of them showed clinical and echographic reduction of ascites. Mean ultrafiltration quantity was 6.084 ml with mean dialysis hours 20; 7.36% of patients had fever that disappeared within 24 hours with antibiotic therapy. All subjects referred to feel well and the mean hospitalization period was of 7 day in spite of the usual 22 days.
机译:背景:在西方国家,过量饮酒会导致继发性,非缺血性心肌病和肝硬化。通常,治疗无效,因此尝试对受影响的患者进行超滤,对生活质量产生积极影响。我们试图验证酒精性心肌病继发于传统疗法难以治愈的一组心力衰竭患者的腹膜超滤效用和耐受性。方法:研究了16例酒精性心肌病合并心力衰竭和腹水的患者(男14例,女2例)。所有受试者均属于NYHA IV级(纽约心脏协会);超声心动图评估射血分数(EF),腹部超声评估腹水。患者接受了临床检查,体重,腹围,利尿和常规生物体液检查,心电图和胸部X光检查。随后,他们进行了间歇性的夜间腹膜透析,每次疗程更换周期为6-12小时。 5天后,通过超声心动图和腹部超声检查对象。结果:患者平均年龄为56.7 +/- 3.2岁。超滤后,所有受试者的体重,腹围和尿素均减少;利尿和尿钠增多。 15名受试者进入了III级NYHA等级,而EF没有变化;它们均显示出腹水的临床和超声检查减少。平均超滤量为6.084 ml,平均透析时间为20; 7.36%的患者发烧并在抗生素治疗后24小时内消失。所有受试者均感觉良好,尽管通常为22天,但平均住院时间为7天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号